Treatment with α-glucosidase inhibitor for severe reactive hypoglycemia: A case report

9Citations
Citations of this article
7Readers
Mendeley users who have this article in their library.

Abstract

Gastrectomy or vagotomy may result in reactive hypoglycemia, which, in some cases, can reduce the plasma glucose levels to 30-40 mg/dl due to rapid digestion and absorption of food, especially carbohydrates. It also occurs sometimes in patients on hemodialysis, where it is a potentially lethal complication. Because insulin has a longer half-life due to lack of renal degradation, hypoglycemia can be induced by insulin in patients with renal failure. We treated a patient with frequent episodes of severe hypoglycemia, that were sometimes accompanied by convulsions. He had undergone total gastrectomy 8 years before and had been maintained on hemodialysis for 3 years. Hyperinsulinemia caused by oxyhyperglycemia associated with post-gastrectomy led to severe hypoglycemia in this patient because of the lack of renal insulin degradation. Since nutritional treatment did not successfully manage his reactive hypoglycemia, an α-glucosidase inhibitor, acarbose, was administered to treat his oxyhyperglycemia. This therapy was very effective and he has not had any recurrence of reactive hypoglycemia since the initiation of the therapy.

Cite

CITATION STYLE

APA

Teno, S., Nakajima-Uto, Y., Nagai, K., Shimizu-Saitoh, M., Ozu, H., Omori, Y., & Takizawa, T. (2000). Treatment with α-glucosidase inhibitor for severe reactive hypoglycemia: A case report. Endocrine Journal, 47(4), 437–442. https://doi.org/10.1507/endocrj.47.437

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Save time finding and organizing research with Mendeley

Sign up for free